Roughly one-third of people diagnosed with major depressive disorder do not achieve adequate relief after two or more antidepressant trials — a condition clinically defined as treatment-resistant depression (TRD). Many Idahoans living across the Magic Valley have tried medication after medication only to find that the hope offered at each appointment quietly fades. At H3O Interventional Psychiatry in Twin Falls, we offer IV ketamine as an off-label option for patients who have reached that difficult crossroads.
Understanding Treatment-Resistant Depression and IV Ketamine
Treatment-resistant depression is not a character flaw or a failure of willpower. It is a neurobiological reality that conventional serotonin-targeting antidepressants, such as SSRIs and SNRIs, simply cannot fully address for every patient. Standard antidepressants work by gradually shifting monoamine neurotransmitter levels over weeks, and for a significant subset of patients, that mechanism is insufficient. IV ketamine works through an entirely different pathway — the glutamatergic system — and specifically targets NMDA receptors. When administered in a controlled clinical setting, sub-anesthetic doses of ketamine can promote rapid synaptogenesis, meaning the brain begins rebuilding synaptic connections that chronic depression has eroded. This off-label use of IV ketamine has been the subject of robust peer-reviewed research over the past two decades, and it remains one of the most studied interventions for patients who have not responded to conventional treatment.
At H3O Interventional Psychiatry, we take the time to understand your complete clinical picture before recommending IV ketamine. Dr. Nicole Bartlett, DNP, PMHNP-BC, conducts thorough evaluations that weigh your depression severity, prior treatment history, medical profile, and the practical realities of your daily life. Not every patient is a candidate, and we believe honest clinical guidance is more valuable than promising any single treatment as a universal cure. Patients who have exhausted multiple antidepressant regimens and who have not found adequate relief with psychotherapy alone are often the individuals we evaluate most carefully for IV ketamine.
A typical course of IV ketamine at our Twin Falls clinic involves a series of infusions delivered over several weeks. Each infusion is administered in a calm, monitored environment, with our clinical team present throughout. Because ketamine is delivered intravenously, the dosing can be precisely controlled, and the time-to-effect tends to be significantly faster than oral antidepressants — many patients report shifts in mood within hours to days after initial infusions rather than the weeks or months associated with traditional medications. We recognize that for patients who have been suffering for years, that speed can feel profound. However, we are also transparent that results vary by individual, and not every patient experiences the same degree or duration of response.
One barrier we frequently hear from patients in southern Idaho is the distance involved in seeking advanced psychiatric care. Twin Falls sits in a region where specialty mental health treatment has historically required traveling to Boise or beyond. We designed H3O Interventional Psychiatry specifically to address that gap. Our clinic is the only TMS provider within 120 miles and the only certified SPRAVATO® provider within 150 miles, and we operate with extended hours Monday through Friday so that patients with demanding work or family schedules are not forced to choose between their livelihood and their mental health.
A second barrier we hear is uncertainty about what IV ketamine actually involves. Many patients arrive having read conflicting things online, some of it alarming and some of it exaggerated in the opposite direction. We welcome those questions. IV ketamine for psychiatric purposes is distinct from recreational or anesthetic ketamine use, and understanding that distinction is part of what we discuss during every evaluation. The doses used in a clinical setting are sub-anesthetic, meaning patients remain conscious and monitored throughout the infusion. Most people describe the experience as a mild dissociative state that resolves before they leave the clinic. We ask that all patients arrange a driver, and we provide detailed preparation guidance ahead of each session.
IV ketamine does not work in isolation for most patients. We typically discuss how ketamine fits within a broader treatment framework, which may include ongoing psychiatric services, medication management, or ketamine-assisted psychotherapy depending on your needs. The goal is not simply to offer a novel intervention — it is to support meaningful, sustained improvement in your quality of life. We ask every patient to discuss with their provider how ketamine integrates with any current medications or therapies before beginning treatment.
For patients in Twin Falls, Jerome, Burley, and the broader Magic Valley, access to evidence-informed, interventional psychiatric care has often meant long drives and long waits. We built H3O Interventional Psychiatry to change that reality for southern Idaho. Results vary by individual, and we will always be honest with you about what the research says and what your personal clinical profile suggests about your likely response. To learn more about how other patients have experienced our care, explore our patient testimonials.
Frequently Asked Questions
What is treatment-resistant depression?
Treatment-resistant depression (TRD) is generally defined as depression that has not responded adequately to at least two different antidepressant medications prescribed at therapeutic doses for an appropriate duration. It does not mean depression is untreatable — it means that conventional first-line approaches have not been sufficient and that more specialized interventions may be appropriate.
Is IV ketamine FDA-approved for depression?
IV ketamine is used off-label for psychiatric indications including depression and treatment-resistant depression. While ketamine is FDA-approved as an anesthetic agent, its use in mental health treatment is considered off-label. Your provider will explain what that means clinically and how the evidence base supports its use in appropriate candidates. For patients who may be candidates for an FDA-approved option, our team also offers Spravato (esketamine) treatment in Twin Falls.
How quickly does IV ketamine work?
Many patients report mood shifts within hours to days following their initial infusions, which is considerably faster than traditional oral antidepressants. However, individual responses vary, and a full series of infusions is typically recommended before drawing conclusions about long-term effect.
How do I know if I’m a candidate for IV ketamine in Twin Falls?
An evaluation with Dr. Nicole Bartlett will assess your diagnosis, treatment history, medical profile, and current medications. Candidacy depends on multiple factors, and we encourage you to discuss with your provider whether IV ketamine is appropriate for your specific situation.
Does insurance cover IV ketamine for depression?
Coverage for IV ketamine varies significantly by insurance plan. Because its psychiatric use is off-label, many plans do not cover it, though some patients find partial coverage through health savings accounts or flexible spending accounts. We recommend contacting your insurer directly and speaking with our team about your options.
Key Takeaways
- Treatment-resistant depression affects roughly one-third of people with major depressive disorder and is defined by inadequate response to at least two antidepressant trials.
- IV ketamine works through the glutamatergic system via NMDA receptor modulation, a fundamentally different mechanism than conventional antidepressants.
- Its use for depression is off-label, meaning it is supported by clinical research but not FDA-approved for that specific indication.
- Results vary by individual, and candidacy is determined through a thorough clinical evaluation with Dr. Nicole Bartlett.
- H3O Interventional Psychiatry in Twin Falls offers IV ketamine as part of a broader treatment framework, including psychiatric services and ketamine-assisted psychotherapy.
Conclusion
Treatment-resistant depression can make every day feel like an exhausting uphill climb, and the disappointment of treatments that do not work compounds the weight of the illness itself. At H3O Interventional Psychiatry, we believe that patients in southern Idaho deserve access to the full range of evidence-informed psychiatric options — not just what happens to be available closest to home. For a deeper look at how advanced approaches are transforming outcomes in the region, read our overview of advanced depression treatments in Idaho. If you have tried multiple antidepressants without adequate relief and want to understand whether IV ketamine might be appropriate for your situation, we encourage you to schedule a consultation with our team. Discuss with your provider whether your history and clinical profile make you a candidate, and take the first step toward understanding what your options genuinely are.
References
National Institute of Mental Health. https://www.nimh.nih.gov/health/topics/depression
American Psychiatric Association. https://www.psychiatry.org/patients-families/depression/what-is-depression
Murrough JW, et al. — Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression. American Journal of Psychiatry. https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2013.13030392
Yale Medicine. https://www.yalemedicine.org/conditions/ketamine-for-depression
About Dr. Nicole Bartlett
Dr. Nicole Bartlett, DNP, PMHNP-BC, leads H3O Interventional Psychiatry in Twin Falls, Idaho, serving patients across southern Idaho who face geographic barriers to advanced psychiatric care. H3O Wellness is the only TMS provider within 120 miles and the only certified SPRAVATO® provider within 150 miles, offering TMS, SPRAVATO®, and IV ketamine under one roof for patients with treatment-resistant depression. Dr. Bartlett conducts thorough evaluations weighing each patient’s depression severity, treatment history, medical profile, and practical needs before recommending TMS, SPRAVATO®, ketamine, or combination approaches — with extended hours Monday through Friday to accommodate all schedules.
Medical Disclaimer
The content on this page is intended for educational purposes only and does not constitute medical advice. Information provided by H3O Interventional Psychiatry is not a substitute for professional medical evaluation, diagnosis, or treatment. Results vary by individual, and no outcomes are guaranteed. Always discuss with your provider before making any changes to your mental health treatment plan. If you are experiencing a mental health emergency, please call 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room.